Nominations for 2020 ICIS-Luminex John R. Kettman Award for Excellence in Interferon & Cytokine Research
The New 2020 ICIS-Luminex John R. Kettman Award for Excellence in Interferon & Cytokine Research, generously supported by Luminex Corporation, recognizes a mid-career investigator who has made outstanding contributions to the field of interferon or cytokine biology. Deadline for nominations: September 15, 2020.
The awardee will receive a $5,000 cash prize that covers meeting registration, and where applicable travel support to the ICIS annual meeting for presentation of his or her research in an award lecture. The award is named after Dr. John R (Jack) Kettman, an immunologist who was instrumental in the development of Luminex’s technologies and the Luminex Corporation.
A nominee must be an ICIS member in good standing* who is within 15 years from their terminal degree (Ph.D., M.D., or equivalent). A nominee must be an independent research scientist (PI); postdoctoral fellows are not eligible. Eligibility of the nominee will be checked at time of nomination and before presentation of award.
Letters of nomination should be sent to the ICIS President via the ICIS website. The nomination package should include:
a full CV of the nominee and a letter of nomination detailing the accomplishments of the nominee and
reasons for the nomination.
A candidate may be nominated by more than one ICIS member. The deadline for this inaugural award is September 15, 2020.
It should be noted that the awardees will be judged based on the following criteria which should be included in the nomination letter:
outstanding publications and ground-breaking discoveries in the field
collective contributions to the field of cytokine biology